Senores Pharmaceuticals relieves Company Secretary from duties
Senores Pharmaceuticals Limited relieved Company Secretary Vinay Kumar Mishra from his duties effective the close of business hours on June 10, 2026, based on his earlier resignation intimation dated May 14, 2026. In compliance with Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company authorized Managing Director Mr. Swapnil Jatinbhai Shah and Whole Time Director and Chief Financial Officer Mr. Deval Rajnikant Shah to determine the materiality of events and information for disclosures to the stock exchanges. The company confirmed that all requisite information, including the copy of the resignation letter, was previously submitted to the exchanges as per the relevant SEBI circular.

*this image is generated using AI for illustrative purposes only.
Senores Pharmaceuticals Limited relieved Company Secretary Vinay Kumar Mishra from his duties effective the close of business hours on June 10, 2026. The company informed the stock exchanges that the relief follows his earlier resignation intimation dated May 14, 2026.
In accordance with Regulation 30(5) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company has designated specific Key Managerial Personnel (KMP) to determine the materiality of events and information for disclosures to the exchanges.
The authorized personnel include Managing Director Mr. Swapnil Jatinbhai Shah and Whole Time Director and Chief Financial Officer Mr. Deval Rajnikant Shah. The contact details for the Managing Director have been provided to facilitate necessary communications.
The company confirmed that the requisite information, including the copy of the resignation letter, was previously submitted to the exchanges as per SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.
Authorized Key Managerial Personnel
| Sr. No. | Name | Designation | Contact Details |
|---|---|---|---|
| 1. | Mr. Swapnil Jatinbhai Shah | Managing Director | Registered Office: 1101 to 1103, 11th floor, South Tower, ONE 42, opposite Jayantilal Park, Ambali Bopal Road, Ahmedabad, Gujarat, India, 380054 Tel.: +91-79-29999857 E-mail: cs@senorespharma.com |
| 2. | Mr. Deval Rajnikant Shah | Whole Time Director and Chief Financial Officer |
Historical Stock Returns for Senores Pharmaceuticals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +11.14% | +23.52% | +34.68% | +68.93% | +137.96% | +131.58% |
Who will be appointed as the new Company Secretary to fill the vacancy left by Vinay Kumar Mishra?
What impact will this leadership change have on Senores Pharmaceuticals' upcoming regulatory compliance and disclosure timelines?
Are there any strategic shifts or internal reorganizations expected following the resignation of the Company Secretary?


































